# Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women

> **NCT05156814** · PHASE4 · UNKNOWN · sponsor: **Scientific Research Institute of Public Health, Russian Federation** · enrollment: 150 (estimated)

## Conditions studied

- Perimenopausal Disorder
- Hot Flashes

## Interventions

- **DRUG:** Femoston® 1, Femoston® 2
- **DRUG:** Duphaston
- **DRUG:** Klimadynon
- **DRUG:** Divigel

## Key facts

- **NCT ID:** NCT05156814
- **Lead sponsor:** Scientific Research Institute of Public Health, Russian Federation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-29
- **Primary completion:** 2022-09
- **Final completion:** 2023-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05156814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05156814, "Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05156814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*